Know AML marks Acute Myeloid Leukemia World Awareness Day 2020

Following the successful Acute Myeloid Leukemia (AML) World Awareness Day (WAD) in 2019, Know AML is pleased to mark AML WAD again in 2020.

AML WAD will take place on April 21, 2020, with the aim of increasing levels of knowledge in AML within the global community through collaborative participation. Know AML are proud to lead the campaign to raise awareness of AML through a series of coordinated activities — Wear it, Badge it, and Share it.

Know AML would like to encourage everyone to get involved, either via social media or through offline activities. We would like you to wear red and black and share a photo; use our digital banners to badge your social media profiles; wear a Know AML pin badge and share a photo; and share our graphics and factsheets — available in multiple languages! To learn more about how to get involved, please visit http://www.know-aml.com/en/get-involved/world-awareness-day.

“Disease awareness is vital in ensuring earlier diagnosis, earlier treatment, and better overall outcomes for patients. This is why the Know AML initiative is so very important. Know AML excels at spreading crucial awareness of AML worldwide — the MDS Foundation is proud to support this initiative.” Tracey Iraca, Patient Advocate, MDS Foundation

“April 21 is Acute Myeloid Leukemia World Awareness Day, but our fight is on a daily basis." Doctor Isolda Fernandez, Physician, Fundaleu Hospital and Clinical Research Center

We gratefully acknowledge the support of professional organizations, who work with Know AML, to distribute resources and knowledge to the wider community across the globe.

“The Know AML awareness initiative is important and The Haematology Nurses & Healthcare Professionals Group (HNHCP) is proud to be a part of it, to achieve the best possible quality of life for patients with AML.” Erik Aerts, Specialist Nurse, HNHCP

“CancerCare is proud to continue supporting the Know AML initiative. Spreading awareness about AML and sharing the resources available to patients is an important part of our mission.” Patricia J. Goldsmith, CEO, CancerCare

About Know AML

Know AML is the first global AML initiative that aims to direct patients, carers, families, and healthcare professionals to the available information, resources, and support they need to deal with AML. Know AML collaborates with a vast global network of advocates, who together ensure that the AML community has access to the latest information and resources, providing the best possible support and care for patients with AML and their families.

“To be able to contribute to the Know AML initiative is very important to me because, as a patient diagnosed with this leukaemia, I know how difficult it can be to find the right support and information when it really matters… I am proud to be an ambassador for Know AML because they understand what is needed and how to achieve it.” Anna Mamwell, AML Patient

Our Mission

To drive awareness of AML globally through community collaborations, while continuing to raise awareness of the resources and support currently available. Know AML aspires to facilitate and improve knowledge of AML worldwide and develop community-based initiatives to overcome current and future challenges.

Know AML is a global initiative steered by an independent multidisciplinary ambassador group, who provide guidance about the development of support and educational materials and resources. The Know AML ambassador group includes representatives from the following AML communities: patients, families, specialist nurses, patient advocacy representatives, leading physicians in AML, and official Know AML supporters.

We would like to extend a special thank you to the 2020 Know AML industry partners: AbbVie (Gold), Amgen (Silver), Astellas (Silver), Bristol Myers Squibb (Silver), Jazz Pharmaceuticals (Silver), Agios (Bronze), Daiichi Sankyo (Bronze), and our contributors.

The Know AML initiative is facilitated by Scientific Education Support (SES). SES take pride in building communities and networks to facilitate education through collaboration and aim to ensure all patients have timely access to the latest support and treatments available.

For media enquires or to be involved please contact secretariat@scientificeducationsupport.com

For more information, please visit our webpage: www.know-aml.com

Follow us on social media: Twitter: @KNOW_AML, Facebook: @KNOWAML, and Instagram: @knowaml